Tango Therapeutics TNGX
NASDAQ TNGX
$23.24 -1.21 (-4.95%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Long-Term Investments (2020 - 2021)

Updated

Tango Therapeutics (TNGX) reported Long-Term Investments of $166.82 million for Q2 2021, unchanged from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Long-Term Investments (2020 - 2021) Analysis & Trends

Dating back to Q3 2020, Tango Therapeutics' Long-Term Investments record includes 4 quarters.

  • Five-year quarterly Long-Term Investments spans a low of $166.76 million in Q3 2020 and a high of $166.82 million in Q4 2020.
  • Per Business Quant data, the three quarters before Q2 2021 came in at $166.81 million (Q1 2021), $166.82 million (Q4 2020) and $166.76 million (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 Tango Therapeutics 4.12 Bn 2.23 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 166.82 Mn
Mar 31, 2021 166.81 Mn
Dec 31, 2020 166.82 Mn
Sep 30, 2020 166.76 Mn
API Access

Tango Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=TNGX&period=max&api_key=YOUR_API_KEY